Funding for this research was provided by:
Takeda Pharmaceuticals U.S.A. (Takeda Pharmaceuticals U.S.A.)
Received: 10 October 2022
Accepted: 23 May 2023
First Online: 17 July 2023
: The study was reviewed and deemed exempt by RTI International’s institutional review board.
: Informed consent for study participation and publication of the study results was obtained from the parents of the patients. A copy of the consent form is available for review by the Editor of this journal.
: SM and NH are employees of RTI Health Solutions. DR is full-time employee and stockholder of Takeda.